2nd Utah Amyloidosis Symposium

Friday- May 17, 2019 ~ 8:00am - 4:00pm
Spencer F. & Cleone P. Eccles Health Sciences Education Building
University of Utah, Salt Lake City


On behalf of the Organizing Committee, it is our great pleasure to invite you to the 2nd Utah Amyloidosis Symposium in Salt Lake City, UT. The 2019 symposium will be held on Friday, May 17, 2019 in the Spencer F. & Cleone P. Eccles Health Sciences Education Building (HSEB), Alumni Hall at the University of Utah. 

This year's symposium will run from 8:00am - 4:00pm.

The objective of the Utah Amyloidosis Symposium is to develop a forum that will catalyze, advocate, and provide education that promotes change, development and improvement for the early diagnosis and management of amyloidosis.



For more information, contact esi@esimgt.com or 877-501-9446/ 801-501-9446.

2019 Keynote Speakers:

Giovanni Palladini, MD, PhD
Light Chain Amyloidosis Focus


  • Acting Director, Amyloidosis Research and Treatment Center, Foundation “Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo” and Department of Molecular Medicine, University of Pavia, Pavia, Italy.


Vaishali Sanchorawala, MD
The Role of Stem Cell Transplant Amidst Emerging Therapies in the Treatment in AL Amyloidosis



  • Director, Autologous Stem Cell Transplant Program; Director, Amyloidosis Center
    Boston University School of Medicine
    Boston, MA


Mathew Maurer, MD
The Changing Landscape in ATTR Amyloidosis


  • Medical director of The HCM Center
    New York-Presbyterian Hospital/Columbia University Medical Center
    New York, NY


Sami L. Khella, MD
The Impact of Gene Silencers in Neuropathy and Quality of Life in Patients with Familial Amyloidosis

Neuropathy Scales for Clinical Practice vs Trials


  • Chief, Department of Neurology, Penn Presbyterian Medical Center
    Philadelphia, PA


Past Events


Grand Rounds: Emerging Therapies for Amyloidosis Cardiomyopathy

Grand Rounds: Amyloidosis: A rapidly moving field